<DOC>
	<DOC>NCT00837941</DOC>
	<brief_summary>The purpose of this study is to determine if analgesic efficacy can be detected with single dose administration in patients with chronic neuropathic pain due to painful diabetic neuropathy.</brief_summary>
	<brief_title>A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)</brief_title>
	<detailed_description />
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Patient has been treated for type 1 or 2 diabetes mellitus with glycosylated hemoglobin Patient has pain in both feet that occurred after onset of diabetes Patient agrees to maintain a consistent activity level throughout the study Patient is not on chronic pain therapy, or is on a stable dose of one pain therapy Female patients of reproductive potential must agree to use two acceptable methods of birth control through out the study Patients taking a pain medication must be on a stable dose at least 1 month prior to participating in study Patient has a history of congestive heart failure Patient has/had a seizure disorder Patient has tried and failed 3 or more drugs to treat neuropathic pain Patient is currently taking pregabalin or duloxetine hydrochloride Patient has had a malignancy within the past 2 years (excluding basal cell carcinoma) Patient has history of hepatitis B or C or HIV infection Patient has skincondition that may decrease sensitivity in area of neuropathic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>